Who
Geoffrey B. Pardo
Director
Company insider
Files Form 4 as: Director, SpyGlass Pharma; Director and 10% owner, Shoulder Innovations; Director, CVRx; Director, Inari Medical; Director, Vapotherm.
In numbers
- Trades disclosed
- 20
- Buys
- 3
- Sells
- 0
- Bought
- $16.4M
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 16 Nov 2018
- Last trade
- 9 Feb 2026
- Last filed
- 11 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —1,875,013 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Bought | $5.0M312,500 at $16.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —1,875,013 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —1,875,013 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —1,875,013 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Bought | $5.0M312,500 at $16.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,400 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,400 at $0.00 | filing |
| 1 Aug 2025filed 5 Aug 2025 | SI Shoulder Innovationsoption or derivative · Medical Devices | SEC FORM 4 Code C | —33,259,424 | filing |
| 1 Aug 2025filed 5 Aug 2025 | SI Shoulder Innovationsoption or derivative · Medical Devices | SEC FORM 4 Code C | —10,252,188 | filing |
| 1 Aug 2025filed 5 Aug 2025 | SI Shoulder InnovationsMedical Devices | SEC FORM 4 Code C | —2,280,482 | filing |
| 1 Aug 2025filed 5 Aug 2025 | SI Shoulder InnovationsMedical Devices | SEC FORM 4 Bought | $1.5M100,000 at $15.00 | filing |
| 1 Aug 2025filed 5 Aug 2025 | SI Shoulder InnovationsMedical Devices | SEC FORM 4 Code A | —7,666 at $0.00 | filing |
| 2 Jul 2021filed 2 Jul 2021 | CVRX CVRxoption or derivative · Medical Devices | SEC FORM 4 Code C | —24,583,397 at $0.00 | filing |
| 2 Jul 2021filed 2 Jul 2021 | CVRX CVRxMedical Devices | SEC FORM 4 Code C | —1,554,022 | filing |
| 2 Jul 2021filed 2 Jul 2021 | CVRX CVRxMedical Devices | SEC FORM 4 Bought | $5.0M275,000 at $18.00 | filing |
| 29 Jun 2021filed 1 Jul 2021 | CVRX CVRxoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,382 at $0.00 | filing |
| 27 May 2020filed 27 May 2020 | Inari Medicaloption or derivative | SEC FORM 4 Code A | $170K8,947 at $19.00 | filing |
| 24 Jul 2019filed 25 Jul 2019 | Vapothermoption or derivative | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
| 16 Nov 2018filed 20 Nov 2018 | Vapothermoption or derivative | SEC FORM 4 Code A | —14,250 at $0.00 | filing |
News
SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL SystemSGP · manilatimes.net · 19 Oct 2026
0 headlines in the last 90 days name Geoffrey B. Pardo; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.